Mercian Corporation
Records under this name other than the patents Mercian Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,148,119 | Hydroxylase Gene and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,735,135 | Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,006,412 | Expression Vector for Pseudonocardia Autotrophica Formerly held In force · High confidence | In force | High confidence | |
| US 8,460,915 | Escherichia coli expressing the cytochrome P-450 gene and a method for microbial conversion using them Formerly held Lapsed on the fee record Ended Jun 11, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 11, 2025 | USPTO record |
| US 8,299,251 | Method for producing camptothecin derivatives Formerly held Lapsed on the fee record Ended Oct 30, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2024 | USPTO record |
| US 7,550,503 | Novel Physiologically Active Substances Formerly held Term ended Term ended Oct 11, 2023 · Medium confidence | Term ended | Term ended Oct 11, 2023 | Medium confidence |
| US 7,667,052 | Novel Bioactive Substance Formerly held Term ended Ended no later than Jun 16, 2023 · Low confidence | Term ended | Ended no later than Jun 16, 2023 | Low confidence |
| US 7,932,083 | DNA Participating in Hydroxylation of Macrolide Compound Formerly held Lapsed on the fee record Ended Apr 26, 2023 · High confidence | Lapsed on the fee record | Ended Apr 26, 2023 | High confidence |
| US 7,893,068 | Physiologically active substances Formerly held Lapsed on the fee record Ended Feb 22, 2023 · USPTO record | Lapsed on the fee record | Ended Feb 22, 2023 | USPTO record |
| US 7,026,352 | Novel Physiologically Active Substances Formerly held Term ended Term ended Feb 1, 2022 · High confidence | Term ended | Term ended Feb 1, 2022 | High confidence |